Collegium Pharmaceutical (COLL) Gross Profit Growth (3y) (2019 - 2026)
Collegium Pharmaceutical (COLL) Gross Profit Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 7.62% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.71% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 12.55% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 76.85% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.80% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.95% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -35.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 37.26% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 44.16% |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn | 14.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.85% |
| Dec 31, 2025 | 37.13% |
| Sep 30, 2025 | 29.97% |
| Jun 30, 2025 | 27.44% |
| Mar 31, 2025 | 26.14% |
| Dec 31, 2024 | 323.09% |
| Sep 30, 2024 | 28.04% |
| Jun 30, 2024 | 21.81% |
| Mar 31, 2024 | 18.05% |
| Dec 31, 2023 | 28.80% |
| Sep 30, 2023 | 18.56% |
| Jun 30, 2023 | 15.14% |
| Mar 31, 2023 | 25.68% |
| Dec 31, 2022 | 25.62% |
| Sep 30, 2022 | 30.97% |
| Jun 30, 2022 | 25.67% |
| Mar 31, 2022 | 24.14% |
| Dec 31, 2021 | -26.63% |
| Sep 30, 2021 | 24.03% |
| Jun 30, 2021 | 24.20% |